It’s The Most Wonderful Time For Micron: A Historic Bargain Before The 2026 Rally (MU)
Seeking Alpha· 2025-12-18 13:45
Micron Technology, Inc. ( MU ) has just published what I can only describe as unbelievable fiscal Q1 results , and I must be honest with you, I was genuinely surprised by the company's beatI write about stocks I’m personally interested in adding to my portfolio. I’m not a professional advisor, but I study business and economics and analyze markets full-time. My writing is meant for both complete beginners — I avoid unnecessary complexity — and advanced readers, as I always aim to offer a distinct and well-r ...
CBM India Extends Relief Support to 2,000 Disaster-Affected Families in Punjab and Uttarakhand
BusinessLine· 2025-12-18 13:45
DEHRADUN, India, Dec. 18, 2025 /PRNewswire/ -- Building on its long-standing commitment to inclusive humanitarian action, CBM India has extended critical relief and recovery support to 2,000 families affected by the recent floods, landslides, and cloudburst in the Chamoli district (Uttarakhand) and Jalandhar district (Punjab). The initiative focuses on post-disaster recovery and aims to ensure that the most marginalized, including persons with disabilities, women, elderly people, and children, can rebuild t ...
Here’s What Supported Vital Farms’ (VITL) Stock Price Surge in Q3
Yahoo Finance· 2025-12-18 13:45
Core Insights - The Wasatch Micro-Cap Fund reported a return of 9.52% in Q3 2025, underperforming the benchmark Russell Microcap® Growth Index, which returned 19.93% [1] - Vital Farms, Inc. (NASDAQ:VITL) was highlighted as a key holding, with a one-month return of 2.60% and a 52-week loss of 15.36% [2][4] - The company reported net revenue of $198.9 million in Q3 2025, reflecting a 37.2% increase from Q3 2024 [4] Company Overview - Vital Farms, Inc. specializes in providing specialty eggs and butter sourced from small farms and pasture-raised animals, catering to a growing consumer focus on sustainable and ethical food sourcing [3] - The company has been expanding its network of farms, which has positively impacted its stock performance, especially after exceeding earnings expectations and raising guidance [3] Investment Considerations - Despite the potential of Vital Farms, it is not among the top 30 most popular stocks among hedge funds, with 33 hedge fund portfolios holding the stock at the end of Q3 2025, up from 23 in the previous quarter [4] - The investment community suggests that certain AI stocks may offer greater upside potential compared to Vital Farms, indicating a competitive landscape for investment opportunities [4]
It's The Most Wonderful Time For Micron: A Historic Bargain Before The 2026 Rally
Seeking Alpha· 2025-12-18 13:45
Micron Technology, Inc. ( MU ) has just published what I can only describe as unbelievable fiscal Q1 results , and I must be honest with you, I was genuinely surprised by the company's beatI write about stocks I’m personally interested in adding to my portfolio. I’m not a professional advisor, but I study business and economics and analyze markets full-time. My writing is meant for both complete beginners — I avoid unnecessary complexity — and advanced readers, as I always aim to offer a distinct and well-r ...
Owlet Announces New DME Partnership With 1 Natural Way to Expand Insurance-Supported Access to BabySat® Infant Pulse Oximeter
Businesswire· 2025-12-18 13:45
"Company†) (NYSE: OWLT), the pioneer of smart infant monitoring, today announced a new durable medical equipment (DME) partnership with 1 Natural Way, a leading national mom-and-baby-focused DME provider. Families nationwide can now access Owlet's FDA-cleared prescription pulse oximeter, BabySat, through insurance-supported pathways on 1NaturalWay.com. Expanding Owlet's DME Reach for Families Who Need It Most 1 Natural Way offers a nation. LEHI, Utah--(BUSINESS WIRE)---- $owlt #babymonitor--Owlet, Inc. (" ...
DiaMedica Therapeutics Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA
Businesswire· 2025-12-18 13:45
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company developing novel treatments for preeclampsia (PE), fetal growth restriction (FGR) and acute ischemic stroke (AIS), today announced completion of a productive in-person pre-IND meeting with the United States Food and Drug Administration (FDA) for a planned study evaluating DM199 in preeclampsia. Minutes from the meeting affirmed the FDA's request for one additional non-clinical, 1. ...
Financial Compass Group Celebrates 20 Years of Financial Guidance Driven by Purpose
Globenewswire· 2025-12-18 13:44
Wellesley Hills, Massachusetts, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Financial Compass Group, LLC (Source: Financial Compass Group, LLC) Financial Compass Group, LLC is commemorating 20 years of serving business owners, individuals, and families with a thoughtful, planning-centered approach to financial decision-making. Since its founding, the firm has focused on helping clients bring structure and clarity to complex financial lives while supporting long-term personal, business, and lifestyle goals through ...
Publicly-Listed VivoPower Sizes Ripple Share Deal at $900M in XRP Value
Yahoo Finance· 2025-12-18 13:43
VivoPower International, a publicly listed energy and digital asset treasury company, said Wednesday it plans to originate up to $300 million worth of Ripple Labs shares for South Korea-based investment firm Lean Ventures. The share deal will proceed under an arrangement the company says would provide indirect exposure to roughly 450 million XRP tokens valued at around $900 million at current prices. The arrangement was disclosed on Tuesday, though VivoPower’s latest SEC filing on the same day does not ...
Do You Have Faith in the Long-Term Outlook of Limbach Holdings (LMB)?
Yahoo Finance· 2025-12-18 13:43
Wasatch Global Investors, an asset management company, released its “Wasatch Micro-Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Microcap stocks reported strong results in the quarter, due to the consistent risk appetite of investors. The fund—Investor Class returned 9.52% in the quarter but lagged the benchmark Russell Microcap® Growth Index’s 19.93% return. In addition, please check the fund’s top five holdings to know its best picks in 2025. In its third-qua ...
Elanco's Credelio Quattro™-CA1 (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Receives First FDA Conditional Approval for Treatment of New World Screwworm in Dogs
Prnewswire· 2025-12-18 13:43
iiiii Credelio Quattro-CA1 now joins Credelio (lotilaner) and Credelio CAT (lotilaner) on the list of companion animal treatment options for New World screwworm, with these other products recently receiving FDA Emergency Use Authorization for the treatment of New World screwworm infestations in dogs and cats, respectively. According to USDA, there have been 14 cases of New World screwworm within 400 miles of the U.S.-Mexico border, all of them related to cattle movement. With detection reaching as close as ...